These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 6642292)

  • 21. The effect of ticlopidine on TIA compared with aspirin: a double-blind, twelve-month follow-up study.
    Tohgi H
    Agents Actions Suppl; 1984; 15():279-82. PubMed ID: 6385652
    [No Abstract]   [Full Text] [Related]  

  • 22. Intracoronary platelet activation in ischemic heart disease: effects of ticlopidine.
    Ugarte M; de Teresa E; Lorenz P; Marin MC; de Artaza M; Martín-Júdez V
    Am Heart J; 1985 Apr; 109(4):738-43. PubMed ID: 3984829
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [New antithrombotic agents. Supplement or competition for the classical anticoagulants].
    Albert FW; Hartert H; Harzer R
    Med Welt; 1978 Jun; 29(26):1085-7. PubMed ID: 672572
    [No Abstract]   [Full Text] [Related]  

  • 24. [Thrombus formation and its prevention during extracorporeal circulation--effect of preoperative administration with the antiplatelet drugs].
    Takayama T
    Nihon Kyobu Geka Gakkai Zasshi; 1984 Dec; 32(12):2076-89. PubMed ID: 6530570
    [No Abstract]   [Full Text] [Related]  

  • 25. Ticlopidine: quo vadis?
    Agents Actions Suppl; 1984; 15():1-312. PubMed ID: 6592940
    [No Abstract]   [Full Text] [Related]  

  • 26. [Prevention of thrombosis of a blood vessel prosthesis using the anti-aggregation drug ticlid].
    Kirichenko AA; Glukhov AI; Goriunov VS; Smirnova LA
    Kardiologiia; 1985 Aug; 25(8):92-3. PubMed ID: 4068475
    [No Abstract]   [Full Text] [Related]  

  • 27. [Evaluation of platelet aggregation in patients treated with ticlopidine].
    Sbalzarini G; Carniti E; Fiorini L; Iezzi BG
    Clin Ter; 1984 Nov; 111(3):247-50. PubMed ID: 6240365
    [No Abstract]   [Full Text] [Related]  

  • 28. [Ticlopidine in the prevention of recurrent cerebral ischemic accidents].
    Herce Muñoz M
    Med Clin (Barc); 1984 Oct; 83(12):517-8. PubMed ID: 6513628
    [No Abstract]   [Full Text] [Related]  

  • 29. [Effect of ticlopidine on peripheral obliterating arteriopathy].
    Stiegler H; Hess H; Mietaschk A; Trampisch HJ; Ingrisch H
    Dtsch Med Wochenschr; 1984 Aug; 109(33):1240-3. PubMed ID: 6381015
    [TBL] [Abstract][Full Text] [Related]  

  • 30. FDA approves rivaroxaban for prevention of deep-vein thrombosis in surgery.
    Aalbers J
    Cardiovasc J Afr; 2011; 22(4):218. PubMed ID: 21881694
    [No Abstract]   [Full Text] [Related]  

  • 31. [Pharmacology of anti-platelet agents].
    Lecompte T; Kher A; Gaillard JL; Samama M
    J Mal Vasc; 1983; 8(1):3-16. PubMed ID: 6302191
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Ticlopidine and coronary surgery.
    Limet R; David JL; Rigo P
    Agents Actions Suppl; 1984; 15():188-98. PubMed ID: 6385646
    [No Abstract]   [Full Text] [Related]  

  • 33. [Oral Rivaroxaban (Xarelto)].
    Peeters S; Warnez M
    J Pharm Belg; 2013 Mar; (1):37-40. PubMed ID: 23638611
    [No Abstract]   [Full Text] [Related]  

  • 34. Blood lipid profile in healthy subjects treated with ticlopidine.
    Violi F; Alessandri C; Iuliano L; Ghiselli A; Perrone A; Balsano F
    Atherosclerosis; 1985 Dec; 58(1-3):291-4. PubMed ID: 4091884
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The influence of ticlopidine on the natural course of retinal vein occlusion.
    Houtsmuller AJ; Vermeulen JA; Klompe M; Zahn KJ; Henkes HE; Baarsma GS; Tijssen J
    Agents Actions Suppl; 1984; 15():219-29. PubMed ID: 6385648
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Management of direct action oral anticoagulants in the peri-operative period and invasive techniques].
    Llau JV; Ferrandis R; Castillo J; de Andrés J; Gomar C; Gómez-Luque A; Hidalgo F; Torres LM;
    Rev Esp Anestesiol Reanim; 2012; 59(6):321-30. PubMed ID: 22633209
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Prevention and medical treatment of polyregional vascular lesions].
    Di Perri T
    Cardiologia; 1985 Nov; 30(11):1021-3. PubMed ID: 3834978
    [No Abstract]   [Full Text] [Related]  

  • 38. Thrombotic etiology of stress ulcers. 1. The effect of anticoagulant and antiplatelet aggregators in the development of stress ulcers in rats.
    Kumashiro R; Pavlides CA; Kholoussy AM; Matsumoto T
    Am Surg; 1983 Aug; 49(8):417-22. PubMed ID: 6614663
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A comparison of the metabolism of clopidogrel and prasugrel.
    Laizure SC; Parker RB
    Expert Opin Drug Metab Toxicol; 2010 Nov; 6(11):1417-24. PubMed ID: 20839914
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Case of thrombotic thrombocytopenic purpura. Successful treatment with ticlopidine].
    Ishii Y; Ebata H; Satoh K; Ueda H; Harada M; Mashiko N; Nouno R; Tanikawa K; Hidaka T
    Rinsho Ketsueki; 1984 Jul; 25(7):1097-102. PubMed ID: 6542155
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.